rs12150327 - KIF18B-DT - NMT1

Magnitude 2.2 · 2 studies on file

Reported associations

  • Pleiotropic genomic variants at 17q21.31 associated with bone mineral density and body fat mass: a bivariate genome-wide association analysis. - European journal of human genetics : EJHG (2022) · Wei XT, Feng GJ, Zhang H, Xu Q, Ni JJ, Zhao M, Yang XL, Tian Q, Shen H, Hai R, Deng HW, Zhang L, Pei YF · PubMed 32963334

    Osteoporosis and obesity are two severe complex diseases threatening public health worldwide. Both diseases are under strong genetic determinants as well as genetically correlated. Aiming to identify pleiotropic genes underlying obesity and osteoporosis, we performed a bivariate genome-wide association (GWA) meta-analysis of hip bone mineral density (BMD) and total body fat mass (TBFM) in 12,981 participants from seven samples, and followed by in silico replication in the UK biobank (UKB) cohort sample (N = 217,822). Combining the results from discovery meta-analysis and replication sample, we identified one novel locus, 17q21.31 (lead SNP rs12150327, NC_000017.11:g.44956910G > A, discovery bivariate P = 4.83 × 10 , replication P = 5.75 × 10 ) at the genome-wide s

  • Pleiotropic loci underlying bone mineral density and bone size identified by a bivariate genome-wide association analysis - Unknown journal (n.d.) · Unknown authors · PubMed 32314116

    ABSTRACT: Summary Aiming to identify pleiotropic genomic loci for bone mineral density and bone size, we performed a bivariate GWAS in five discovery samples and replicated in two large-scale samples. We identified 2 novel loci at 2q37.1 and 6q26. Our findings provide insight into common genetic architecture underlying both traits. Introduction Bone mineral density (BMD) and bone size (BS) are two important factors that contribute to the development of osteoporosis and osteoporotic fracture. Both BMD and BS are highly heritable and they are genetically correlated. In this study, we aim to identify pleiotropic loci associated with BMD and BS. Methods We conducted a bivariate genome-wide association (GWA) analysis of hip BMD and hip BS in 6180 participants from 5 samples, followed by in sili


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • Bone health and osteoporosis prevention strategy High

    Genetic predisposition to lower hip bone mineral density increases fracture and osteoporosis risk; personalized prevention approach optimizes outcomes

Exercise

  • Weight-bearing and resistance exercise High

    Weight-bearing exercise and resistance training mechanically stress bone tissue, stimulating osteoblast activity and increasing bone mineral density; particularly important given genetic predisposition

    30 minutes of weight-bearing or resistance exercise 3-4 times per week

Screening

  • Hip bone density screening via DXA High

    Carrier of genetic variant strongly associated with reduced hip bone mineral density; DXA screening enables early detection and risk stratification

    Order dual-energy X-ray absorptiometry (DXA) scan for baseline hip and spine bone mineral density assessment

Supplements

  • Vitamin D and calcium supplementation High

    Vitamin D and calcium are critical cofactors for bone mineralization; individuals with genetic predisposition to lower BMD benefit from optimal intake

    Vitamin D 1000-2000 IU daily; calcium 1000-1200 mg daily or per dietary assessment